Evaluation of the psychosocial impact of the MiniMed variable-rate implantable insulin pump.
We examined the psychosocial impact of treatment with an implantable insulin pump among persons with insulin-dependent diabetes mellitus (IDDM). Of specific interest was whether use of the MiniMed implantable insulin pump (MIP) resulted in changes in functional status, performance of diabetes self-care behavior, psychologic symptoms, and perceived level of stress. From a sample of 36 patients with IDDM, 10 persons were randomly selected to receive the MIP, while the remaining 26 served as control subjects. Additionally, a nonrandom sample of three MIP recipients from an additional site were included in the MIP group. At regular assessment intervals, all participants completed self-report questionnaires regarding psychosocial functioning and monitored blood glucose levels. After 4 months of MIP use, MIP recipients did not significantly differ from control subjects on any measure of psychosocial functioning; however, MIP use did have an impact on diabetes self-care. The MIP users monitored their blood glucose levels more frequently and had lower average blood glucose levels than control subjects. Additional follow-up is needed to determine the long-term psychosocial impact of implantable insulin pump therapy.
Barrett
D H
DH
Behavioral Medicine Institute of Atlanta, GA, USA.
Davidson
P C
PC
Steed
L J
LJ
Abel
G G
GG
Loman
K E
KE
Saudek
C D
CD
D000328:Adult; D015190:Blood Glucose Self-Monitoring; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000523:psychology; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000523:psychology*; D007328:Insulin / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D018434:Sickness Impact Profile
D007328:Insulin